Business
The big money
Which are the richest pharmaceuticals companies in the world? And how much do they earn? Despite a number of mergers, sell-offs, buyouts and the emergence of some new specialist blockbuster …
“Strong” position has led to investments
Despite facing PBS reform and intense competition, API reports $25 million net profit after tax and $2 billion in revenue in its half-year results for 2019 Australian Pharmaceutical Industries (API) …
Is the Guild ‘a major barrier’ for pharmacists moving forward?
A distinguished former public servant has criticised the Pharmacy Guild over its approach to professional services, but it says his comments are ‘out of date and out of touch’ “Pharmacists …
Budget business boost
Small businesses set to benefit from a number of budget measures Community pharmacies and other small businesses have been given tax cuts and a range of other financial assistance measures …
It’s over for API-Sigma merger
Sigma’s Board has rejected the API proposal to take it over as not in the best interest of Sigma shareholders The non-binding indicative proposal from API to acquire all Sigma’s …
Retail pharmacy growth, revenue decline from PBS reforms
EBOS Group reports solid first half having acquired Terry White Group and anticipating start of its $1 billion Chemist Warehouse contract in July EBOS Group has released its financial results …
Sigma affirms ‘strong future’
A review initiated after losing My Chemist/Chemist Warehouse supply contract has identified over $100m per year in savings Sigma Healthcare Limited has announced a “strong outlook” after conducting a review …
Hitting your targets
What are the key performance measures that you should focus on for your pharmacy? Here’s what Natalie Sirianni suggests As a ‘numbers’ person, I always love this time of year …
CWH contract loss an ‘opportunity’
API thinks it has a better chance of merging with Sigma second-time around following PBS reforms and a changed industry landscape Last Friday Australian Pharmaceutical Industries Limited (API) announced that …
API announces proposal to merge with Sigma
Under the scheme, API shareholders would own approximately 63% of the combined entity with Sigma shareholders owning the remaining 37% Australian Pharmaceutical Industries Limited (API) has today lodged a substantial …